Cargando...
Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
PURPOSE OF REVIEW: This paper aims to summarize the data of recently completed and key ongoing clinical trials of systemic agents for advanced hepatocellular carcinoma (aHCC). In particular, the review focuses on ongoing checkpoint inhibitor combination trials and promising studies combining tyrosin...
Guardado en:
| Publicado en: | Curr Hepatol Rep |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7848044/ https://ncbi.nlm.nih.gov/pubmed/33552839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-021-00560-2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|